Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma clinical trial (NCT02945800). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of nab-paclitaxel and gemcitabine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma clinical trial (NCT02945800). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma clinical trial (NCT02945800). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma clinical trial (NCT02945800). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma clinical trial (NCT02945800). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma clinical trial (NCT02945800). Contact the study team or your healthcare provider for specific answers.

What this study is about